LOVE-HF

  • Research type

    Research Study

  • Full title

    Lancashire Objective Volume Evaluation of leg oedema in Heart Failure (LOVE-HF) Pilot Randomised Controlled Cross-over Trial programme (LOVE-HF and LOVE-HF-2)

  • IRAS ID

    289790

  • Contact name

    Kenneth Wong

  • Contact email

    dr.wong@bfwhospitals.nhs.uk

  • Sponsor organisation

    Heartfelt Technologies Ltd

  • Clinicaltrials.gov Identifier

    NCT04787380

  • Duration of Study in the UK

    1 years, 11 months, 31 days

  • Research summary

    We are assessing how good changes in foot volume detected by a new medical device can be at detecting heart failure decompensation, and reducing the risk of hospital admission.
    Swollen ankles are caused by a build-up of fluid (oedema); if it can be identified, by asking patients to report symptoms or weight gain, it has been shown to help reduce the risk of hospitalisation. However, many patients get hospitalised because they have not been able to notice or report such changes. We are looking to establish if this type of device could help those patients in future.
    The device we are investigating is installed in the patients’ home and scans their feet from a distance, as they walk around or get in and out of bed, to measure the volume of their ankle. This data can be sent to the patient's doctor who will determine if the patient requires a change to their medication.
    It is important that, before recommending a new device to patients we compare it to the current standard of care, which is regular weighing and symptom reporting (the target audience for this device is unable to do this regularly).
    The study will be run in 2 phases. In the first, participants will be randomly allocated to one of two arms: in one the device will not report any data to their doctor (standard care only), and in the other arm the device will report alerts for the doctor (Heartfelt + standard care). In LOVE-HF-2, participants will randomly be allocated to one of two arms, either Heartfelt + reporting symptoms, or weighing + reporting symptoms (standard care only).

    In both parts of the study after 30 days, the participants will be crossed over the other arm.

  • REC name

    London - City & East Research Ethics Committee

  • REC reference

    21/PR/0057

  • Date of REC Opinion

    16 Feb 2021

  • REC opinion

    Favourable Opinion